Veeva Systems Expands AI-Driven CRM Partnership with Roche
Veeva Systems Inc. (NYSE: VEEV) has announced an expanded partnership with Roche Pharmaceuticals to implement its AI-powered Vault CRM globally. The integration, slated for December 2025, will leverage Veeva AI Agents—including Free Text, Voice, Pre-call, and Media functionalities—to enhance personalized engagement with healthcare professionals.
The collaboration underscores Veeva's growing dominance in life sciences software, with CEO Peter Gassner highlighting the transformative potential of AI-enabled CRM tools for Roche's pharma teams. VEEV shares traded at $244.34 on November 24, 2025, reflecting a 16.05% year-to-date gain that outpaces the S&P 500.